Trials / Completed
CompletedNCT01726270
An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms
A 8-week, Open-label, Uncontrolled, Exploratory Actual Use Study of Tamsulosin 0.4mg in Men With Prostate Urinary Symptoms in a Simulated Over-the-Counter Environment
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 689 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- Male
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
Multicenter trial conducted in Pharmacy retail centers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | tamsulosin | 0.4 mg |
Timeline
- Start date
- 2012-11-01
- Primary completion
- 2013-03-01
- Completion
- 2013-03-01
- First posted
- 2012-11-14
- Last updated
- 2020-03-27
- Results posted
- 2020-03-27
Locations
18 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01726270. Inclusion in this directory is not an endorsement.